Endocrinology

Top Story

Diagnostic PET/CT should be used with caution in high-risk adrenal cases

Diagnostic PET/CT should be used with caution in high-risk adrenal cases
May 29, 2016

ORLANDO, Fla. — In patients at high-risk for adrenal malignancy, 18F-fluorodeoxyglucose-PET/CT imaging should be used with clinical judgment because of low sensitivity and specificity in this population, according to study findings presented here.

In a retrospective study, Danae Delivanis, MD, a second-year endocrine fellow at Mayo Clinic, and colleagues examined the performance of 18F-fluorodeoxyglucose(18FDG)-PET/CT imaging in a population at high risk for adrenal malignancy. The researchers evaluated data from 352 patients (62.5% men; median age, 68 years; age range, 18-91 years) referred for adrenal biopsies due to suspected or confirmed extra-adrenal malignancy between 1994 and 2014. Malignant adrenal lesions were present in 223 cases and benign lesions in 129. Histology yielded the reference standard in all patients.

Meeting News Coverage

Metabolic syndrome rate, severity in PCOS reduced following bariatric surgery

May 28, 2016
ORLANDO, Fla. — Bariatric surgery can improve cardiometabolic health in women with polycystic ovary syndrome and obesity, according to findings of a retrospective…
Meeting News Coverage

Obesity linked with increased inflammatory markers in type 2 diabetes

May 28, 2016
ORLANDO, Fla. — High sensitivity C-reactive protein levels and white blood cell counts are increased in patients with type 2 diabetes and obesity, according to…
Meeting News Coverage

Vitamin D deficiency may confer risk for retinopathy in diabetes

May 28, 2016
ORLANDO, Fla. — Patients with diabetic retinopathy are more likely to have lower 25-hydroxyvitamin D levels vs. healthy controls, according to a speaker…
Meeting News Coverage

Once-weekly levothyroxine effective hypothyroidism treatment in women

May 28, 2016
ORLANDO, Fla. — Switching from a once-daily dose of levothyroxine to a once-weekly dose that is 7 times the amount of the daily dose is effective for treating…
More News Headlines »
CME

Obesity Consults® ObesityForum® 2015 Highlights

This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. and Novo Nordisk, Inc.

Obesity has increased dramatically in the past 20 years and is considered a health care epidemic in the United States…
More »
Video
Meeting News Coverage

VIDEO: Breaks in sitting time reduce cardiometabolic risk factors in type 2 diabetes

May 4, 2016
More »
Featured
Highlights from AACE

Highlights from AACE

CME Video

Navigating a New Era of Personalized Type 2 Diabetes Care: Taking the Road Less Traveled

This activity is supported by an independent educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

In the United States, over 29 million people have diabetes, of which approximately 95% of cases are type 2 diabetes…
More »
Current Issues
View the Current Issues
morganatic-roan
morganatic-roan